More about

Lipoprotein

News
January 17, 2025
5 min read
Save

The year in lipids: Progress in Lp(a) management and a blow to the ‘HDL hypothesis’

The year in lipids: Progress in Lp(a) management and a blow to the ‘HDL hypothesis’

In 2024, there were numerous trials and a few regulatory moves related to advancements in lipid management for the prevention of major adverse CV events.

News
December 23, 2024
5 min read
Save

Lack of Lp(a) screening a ‘missed opportunity’; promising therapies on the horizon

Lack of Lp(a) screening a ‘missed opportunity’; promising therapies on the horizon

Improved screening for elevated lipoprotein(a) levels among all adults may improve CVD risk assessment and outcomes, especially with multiple Lp(a)-lowering therapies currently in the research pipeline, a speaker reported.

News
November 25, 2024
2 min read
Save

Top in cardiology: Emails improve flu vaccine uptake; out-of-hospital cardiac arrest rate

Top in cardiology: Emails improve flu vaccine uptake; out-of-hospital cardiac arrest rate

Vaccine update improved among adults in Denmark who received email messages that emphasized the cardiovascular benefits of the influenza vaccine, especially among patients with acute myocardial infarction history, researchers found.

News
November 18, 2024
3 min read
Save

First investigational oral therapy lowers Lp(a) in phase 2 study

First investigational oral therapy lowers Lp(a) in phase 2 study

CHICAGO — Adults with elevated liproprotein(a) at high risk for a CV event saw substantial reductions over 12 weeks with muvalaplin, an investigational oral small molecule Lp(a) inhibitor, data from a phase 2 study show.

News
September 01, 2024
3 min read
Save

Measuring three factors can predict women’s 30-year risk for heart disease

Measuring three factors can predict women’s 30-year risk for heart disease

A single combined measure of three modifiable biomarkers in healthy women at midlife was predictive of 30-year risk for future cardiovascular events, according to new research presented at the European Society of Cardiology Congress.

News
August 05, 2024
2 min read
Save

Top in cardiology: AHA calculator may reduce care eligibility; predicting atherosclerosis

Top in cardiology: AHA calculator may reduce care eligibility; predicting atherosclerosis

An estimated 16 million U.S. adults who qualified for statin and/or antihypertensive therapy would not be eligible for primary prevention under the American Heart Association’s new PREVENT risk calculator, researchers reported in JAMA.

News
July 30, 2024
4 min read
Save

Lp(a) could inform risk stratification of patients with a calcium score of 0

Lp(a) could inform risk stratification of patients with a calcium score of 0

Elevated lipoprotein(a), despite a coronary artery calcium score of 0, could portend coronary plaque burden and may be a potential marker for early atherosclerosis intervention, researchers reported.

Clinical Guidance
Lipid Management
Treatment Approaches

Lomitapide

Jennifer G. Robinson, MD, MPH

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Lipid Management
Treatment Approaches

Niacin

Jennifer G. Robinson, MD, MPH

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Lipid Management
Treatment Approaches

Ezetimibe

Jennifer G. Robinson, MD, MPH

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

View more